Deep Learning-Based Segmentation of Head and Neck Organs-at-Risk with Clinical Partially Labeled Data.
DL
automated segmentation
head and neck radiotherapy
longitudinal data
organs-at-risk
partially labeled
Journal
Entropy (Basel, Switzerland)
ISSN: 1099-4300
Titre abrégé: Entropy (Basel)
Pays: Switzerland
ID NLM: 101243874
Informations de publication
Date de publication:
15 Nov 2022
15 Nov 2022
Historique:
received:
30
09
2022
revised:
28
10
2022
accepted:
09
11
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
25
11
2022
Statut:
epublish
Résumé
Radiotherapy is one of the main treatments for localized head and neck (HN) cancer. To design a personalized treatment with reduced radio-induced toxicity, accurate delineation of organs at risk (OAR) is a crucial step. Manual delineation is time- and labor-consuming, as well as observer-dependent. Deep learning (DL) based segmentation has proven to overcome some of these limitations, but requires large databases of homogeneously contoured image sets for robust training. However, these are not easily obtained from the standard clinical protocols as the OARs delineated may vary depending on the patient's tumor site and specific treatment plan. This results in incomplete or partially labeled data. This paper presents a solution to train a robust DL-based automated segmentation tool exploiting a clinical partially labeled dataset. We propose a two-step workflow for OAR segmentation: first, we developed longitudinal OAR-specific 3D segmentation models for pseudo-contour generation, completing the missing contours for some patients; with all OAR available, we trained a multi-class 3D convolutional neural network (nnU-Net) for final OAR segmentation. Results obtained in 44 independent datasets showed superior performance of the proposed methodology for the segmentation of fifteen OARs, with an average Dice score coefficient and surface Dice similarity coefficient of 80.59% and 88.74%. We demonstrated that the model can be straightforwardly integrated into the clinical workflow for standard and adaptive radiotherapy.
Identifiants
pubmed: 36421515
pii: e24111661
doi: 10.3390/e24111661
pmc: PMC9689629
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Asociación Es-pañola Contra el Cáncer and European Regional Development Fund "Una manera de hacer Eu-ropa"
ID : PI18/01625
Organisme : Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos III, Asociación Es-pañola Contra el Cáncer and European Regional Development Fund "Una manera de hacer Europa"
ID : AC20/00102
Organisme : NVIDIA Applied Research Accelerator Program
ID : NA
Organisme : ERA Permed and Rennes Métropole
ID : NA
Références
Phys Med Biol. 2022 Aug 18;67(17):
pubmed: 35878613
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):677-684
pubmed: 30836167
Radiother Oncol. 2021 Jul;160:185-191
pubmed: 33984348
Med Phys. 2019 Feb;46(2):576-589
pubmed: 30480818
Med Phys. 2021 Oct;48(10):5862-5873
pubmed: 34342878
Cancer Med. 2022 Mar;11(6):1553-1560
pubmed: 35029329
Radiother Oncol. 2022 Sep;174:52-58
pubmed: 35817322
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221105724
pubmed: 35790457
J Med Internet Res. 2021 Jul 12;23(7):e26151
pubmed: 34255661
Radiother Oncol. 2020 Mar;144:152-158
pubmed: 31812930
Med Phys. 2019 Sep 16;:
pubmed: 31529501
J Med Imaging (Bellingham). 2020 Sep;7(5):055001
pubmed: 33102622
Cancers (Basel). 2021 Feb 09;13(4):
pubmed: 33572310
JAMA Netw Open. 2020 Nov 2;3(11):e2027426
pubmed: 33252691
Cancer Radiother. 2021 Oct;25(6-7):607-616
pubmed: 34389243
Int J Comput Assist Radiol Surg. 2022 Nov;17(11):2103-2111
pubmed: 35578086
Med Phys. 2019 Nov;46(11):5086-5097
pubmed: 31505046
Clin Oncol (R Coll Radiol). 2022 Feb;34(2):74-88
pubmed: 34996682
Evid Based Complement Alternat Med. 2021 Mar 5;2021:8894222
pubmed: 33747116
Med Phys. 2021 Nov;48(11):7052-7062
pubmed: 34655077
Phys Imaging Radiat Oncol. 2020 Jul 10;15:8-15
pubmed: 33458320
Front Oncol. 2021 May 05;11:638197
pubmed: 34026615
Radiat Oncol. 2022 Feb 8;17(1):28
pubmed: 35135569
J Radiat Res. 2021 Jan 1;62(1):94-103
pubmed: 33029634
Phys Imaging Radiat Oncol. 2020 Oct 14;16:54-60
pubmed: 33458344
Radiother Oncol. 2020 Jan;142:115-123
pubmed: 31653573
Phys Imaging Radiat Oncol. 2021 Jul 28;19:96-101
pubmed: 34746452
Biomed Eng Lett. 2022 Mar 18;12(2):175-183
pubmed: 35529346
Radiother Oncol. 2015 Oct;117(1):83-90
pubmed: 26277855
Phys Med Biol. 2020 Nov 20;65(23):
pubmed: 33086205
Phys Med Biol. 2022 Jun 22;67(11):
pubmed: 35134792
Eur Radiol. 2019 Apr;29(4):1961-1967
pubmed: 30302589
Phys Med Biol. 2021 Sep 14;66(18):
pubmed: 34450599
Front Oncol. 2022 Aug 29;12:936134
pubmed: 36106100
J Med Radiat Sci. 2022 Sep 23;:
pubmed: 36148621